William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.
Equity Research
Matt Phipps Reacts to Medicare Drug Pricing Announcement in Barron’s
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights
Our Latest News
-
Heartflow, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Heartflow, Inc. (HTFL $29.76), a medical technology company focused on AI-enabled cardiovascular solutions that help detect, diagnose, and manage coronary artery disease (CAD) using noninvasive cardiac CT imaging.
-
-